April 2024 Newsletter
April 11, 2024
New Animal Models Humanized Immune-Checkpoint Mice Product Catalog Number B-hCRTAM mice 112532 B-hCD28/hGPC3 mice 113297 B-hMICB mice 112152 B-hRAGE mice plus 113157 B-hCD3E/hCD79B mice 113312 B-hCD28/hPSMA mice 113315 B-hCD3EDG/hGPC3 mice 113317 Humanized Cytokine Mice Product Catalog Number B-hSORT1 mice plus 112493 B-hTAU mice 110953 B-hIL17RA/hIL17RB/hIL25 mice 113268 Humanized GPCR Mice Product Catalog Number […]
Immuno-Oncology Summit Europe 2024: April 23-25
Visit Our Bispecific Antibody Poster at IO Summit Europe 2024! Biocytogen’s antibody Business Development & Licensing team is excited to attend the upcoming Immuno-Oncology Summit Europe 2024 conference, set to take place in London, UK, from April 23-25, 2024! During the event, our team will present a poster, titled “Fully human conditional agonist 4-1BB […]
Festival of Biologics USA 2024: April 15-17
Thank you to those who joined us at the Festival of Biologics USA 2024 from April 15-17 in San Diego, CA! Our Poster titled “Generation of a TAA Antibody Library to Support the Development of Antibody-Drug Conjugates (ADC)” is now available for download using the link below. Download Poster Poster Summary: Biocytogen’s antibody […]
Webinar: Empowering Discovery and Development of Bispecific ADCs With a Common Light Chain Antibody Library and a Novel Linker/Payload
Our webinar will be live at 12:00 PM EDT on April 24th, 2024. Register Now About the webinar Bispecific ADCs are a growing trend in the ADC field, offering improved efficacy and safety for the treatment of heterogeneous solid tumors. Designing bsADCs requires careful selection of targets, and is not without challenges, including the […]
AACR 2024 Posters
We are thrilled to have had the opportunity to attend the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA. Your interest in our research progress and the insightful discussions we had about your projects and objectives truly made our experience at AACR memorable. These exchanges are invaluable in advancing our […]
Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates
Beijing, China, March 25, 2024 –Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, and ABL Bio Inc. (“ABL”, KOSDAQ: 298380), a Korean clinical-stage biotechnology company developing novel therapeutics in oncology and CNS diseases, today announced a collaboration to […]
BIO-Europe Spring 2024 | Schedule 1-on-1 Meetings with Biocytogen
Biocytogen’s antibody BD and licensing team is pleased to attend and host 1-on-1 meetings at BIO-Europe Spring, taking place March 18-20, 2024 in Barcelona, Spain. Biocytogen’s antibody therapeutics R&D division, RenBiologics, offers antibody sequence licensing/co-development, and RenMice® fully human antibody/TCR discovery platform licensing opportunities. RenBiologics: Our Fully Human Library. Your Pipeline. Our team of antibody […]
Join us at World ADC London 2024: Mar 13-14
Join us at the World ADC London 2024 conference in London, UK from March 13-14! Our Chief Scientific Officer and Senior Director of New Drug Development, Dr. Benny Yang, will be presenting “RenBiologics is at the forefront of advancing bispecific ADCs and nanobody ADCs” at 12:30 PM on March 13th. Speaker Session Presenter: Dr. Benny […]
Join us at SAPA-GP Annual Conference 2024: Mar 8-9
Join us at the SAPA-GP Annual Conference 2024 in Pennsylvania from March 8-9, 2024! Whether you need humanized models, pharmacology services, or are seeking antibody partnerships, we’d love to connect with you to learn more about your research objectives. Attend the meeting Talk to us The event typically features presentations and panel discussions from […]
Webinar: Translational Animal Models of Atopic Dermatitis (AD) for Preclinical Studies
February 28, 2024
Our webinar “Translational Animal Models of Atopic Dermatitis (AD) for Preclinical Studies” was live at 12PM EDT on March 27, 2024. About the webinar: Atopic Dermatitis is a chronic inflammatory skin condition characterized by redness, cracking, and scaling, often leading to painful sores. While the precise cause of AD remains unclear, a dysfunctional epidermal barrier […]
